nicotinamide/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on melanoma incidence
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.FindingNull result“No difference in risk of melanoma was observed with nicotinamide compared to control (RR 0.89 (95% CI, 0.29-2.79; I 2 = 0%; 416 patients; 2 trials)).”
Quoted verbatim from Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Participants
- 416
- Population
- Pooled randomised trials of nicotinamide versus control, mainly tertiary skin-cancer prevention populations (2 trials)
Effect 0.89 risk ratio, 95% CI 0.29 to 2.79
Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.2022PMID:35134311Permalink
Keep reading
- Everything the graph holds on nicotinamide
- Every compound studied against Melanoma incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45P6E3M27MAB0B92Y7VATPH